Mater Misericordiae Limited

Brisbane, Queensland 4101

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, Renal Cell Carcinoma, Type 2 Diabetes Mellitus

Studies at this site

• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes — Completed
• Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma — Completed
• Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer — Running, not enrolling